Bing Z Carter Selected Research

X-Linked Inhibitor of Apoptosis Protein

10/2009	Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.
9/2009	Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells.
5/2008	Therapeutic Molecular Targetingof 15-Lipoxygenase-1 in Colon Cancer.
5/2008	Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.
5/2005	Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Z Carter Research Topics

Disease

29	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 05/2002
20	Neoplasms (Cancer) 04/2022 - 07/2006
16	Leukemia 04/2022 - 05/2005
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2020 - 02/2006
6	Blast Crisis (Blast Phase) 09/2020 - 02/2006
4	AIDS-Related Complex (ARC) 01/2019 - 01/2011
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 05/2008 - 05/2008
2	Colorectal Neoplasms (Colorectal Cancer) 05/2008 - 05/2008
2	Philadelphia Chromosome 10/2006 - 02/2006
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2021
1	Anemia 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 09/2020
1	Inflammation (Inflammations) 01/2019
1	Necrosis 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2017
1	Hypoxia (Hypoxemia) 06/2016
1	Rheumatic Fever (Acute Articular Rheumatism) 10/2014
1	Ovarian Neoplasms (Ovarian Cancer) 11/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2009
1	Acute Promyelocytic Leukemia 03/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2005

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
7	Imatinib Mesylate (Gleevec)FDA Link 09/2020 - 02/2006
7	SurvivinIBA 07/2012 - 09/2003
5	triptolideIBA 04/2022 - 07/2006
5	venetoclaxIBA 01/2022 - 01/2020
5	CaspasesIBA 01/2019 - 12/2003
5	X-Linked Inhibitor of Apoptosis ProteinIBA 10/2009 - 05/2005
4	Tyrosine Kinase InhibitorsIBA 04/2022 - 10/2015
4	CateninsIBA 09/2020 - 06/2016
4	bcr-abl Fusion ProteinsIBA 01/2016 - 10/2006
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 11/2019
3	Phosphotransferases (Kinase)IBA 11/2019 - 11/2010
3	Pharmaceutical PreparationsIBA 04/2016 - 05/2008
3	Caspase 3 (Caspase-3)IBA 05/2008 - 09/2003
2	nutlin 3IBA 04/2022 - 01/2010
2	Decitabine FDA Link 01/2022 - 10/2015
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2014
2	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2021 - 09/2020
2	Histone Deacetylase InhibitorsIBA 09/2020 - 11/2006
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020 - 01/2017
2	Inhibitor of Apoptosis ProteinsIBA 01/2019 - 11/2006
2	Biomarkers (Surrogate Marker)IBA 11/2016 - 07/2012
2	LigandsIBA 04/2016 - 04/2008
2	RNA (Ribonucleic Acid)IBA 01/2016 - 05/2014
2	birinapantIBA 11/2014 - 02/2014
2	Caspase 8 (Caspase-8)IBA 02/2014 - 05/2005
2	Antisense OligonucleotidesIBA 08/2013 - 10/2009
2	AEG 35156IBA 05/2013 - 10/2009
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2011 - 10/2009
2	DiterpenesIBA 09/2009 - 07/2006
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2007 - 05/2002
2	Mitogen-Activated Protein KinasesIBA 11/2006 - 05/2002
1	CarbohydratesIBA 01/2022
1	AZD5991IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	tapotoclaxIBA 01/2022
1	c-Mer Tyrosine KinaseIBA 01/2022
1	LCL161IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	DS-5272IBA 01/2020
1	PND 1186IBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Fas Ligand Protein (Fas Ligand)IBA 01/2019
1	P-2 (P 2)IBA 01/2017
1	NickelIBA 11/2016
1	pyrithioneIBA 11/2016
1	Chemokine ReceptorsIBA 04/2016
1	ChemokinesIBA 04/2016
1	Proteoglycans (Proteoglycan)IBA 01/2016
1	Antirheumatic Agents (DMARD)IBA 10/2014
1	Auranofin (Ridaura)FDA Link 10/2014
1	Biological ProductsIBA 08/2013
1	Beclin-1IBA 11/2010
1	Dasatinib (BMS 354825)FDA Link 11/2010
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 10/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008
1	Masoprocol (Actinex)FDA Link 04/2007
1	RetinoidsIBA 03/2007
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 03/2007
1	trichostatin A (A 300)IBA 11/2006
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2006
1	6- ((3- chloro)anilino)- 2- (isopropyl- 2- hydroxyethylamino)- 9- isopropylpurineIBA 11/2006
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 11/2006
1	shepherdinIBA 08/2006
1	Effector CaspasesIBA 05/2005

Therapy/Procedure

9	Therapeutics 04/2022 - 07/2012
5	Drug Therapy (Chemotherapy) 01/2021 - 11/2006
1	Transplantation 01/2020
1	Ligation 03/2007
1	Radiotherapy 11/2006